PREVALENCE OF OPHTHALMIC MANIFESTATIONS IN PATIENTS WITH DIFFUSE TOXIC GOITER IN TEHRAN

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

ARDESHIRI M.; DAFTARIAN N.; MEHRABI YAD ELAH; AZIZI F.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Endocrinology & Metabolism Year:2005 | Volume:7 | Issue:3 (SN 27) Page(s): 217-222

Download Full-Text

Persian Verion

View:

1,819

Download:

Cites:

Information Journal Paper

Title

PREVALENCE OF OPHTHALMIC MANIFESTATIONS IN PATIENTS WITH DIFFUSE TOXIC GOITER IN TEHRAN

Author(s)

ARDESHIRI M. | DAFTARIAN N. | MEHRABI YAD ELAH | AZIZI F. | Issue Writer Certificate

Keywords

GRAVE'S OPHTHALMOPATHYQ3

Abstract

Introduction: Graves' disease is a very common thyroid disease with ophthalmopathy being the most obvious extrathyroid manifestation of this disease. The ocular changes include proptosis, eyelid edema, conjunctivitis, chemosis, extraocular muscle involvement, corneal ulcer, optic neuritis and blindness. This study was conducted to determine the factors that aggravate the severity and activity of the disease. Materials and methods: This is a descriptive study performed on 117 patients (aged 14 to 74 years) with Graves' ophthalmopathy, referring to a private endocrine clinic in Tehran, between January and November 2002. Following completion of a questionnaire for each patient, thyroid and ophthalmologic examination were done. The second ophthalmologic examinations was conducted after an interval of one to three months, for evaluation of activity. Correlations between severity and activity with factors such as sex, age, duration of disease, smoking, thyroid function and treatment with Iodine were evaluated.Results: Evaluation of subjects revealed the following prevalences: lid retraction 91.4% only signs, no symptoms 91.4%, soft tissue swelling 17.9%, proptosis 56.4%, extraocular muscle(EOM) involvement 13.7%, optic neuritis 5.1%, and none had corneal ulcer. EOM involvement was higher in men than in women. (27.8% vs. 7.4%) (P<0.05). The prevalence of active ophthalmopathy was higher in men than in women (69.4%compared to 35.8%) (P<0.001)and lower in patient that had iodine ablation 33.3% vs. 62% ( P<0.003). Statistics of subjects seen to have autoimmune disease and family histories of thyroid disease were 8.6% and 47.9% respectively. In both sexes smoking was higher than in the general population (P<0.01). Conclusion: This study revealed that, as compared to other countries, Graves' ophthalmopathy is seen to occur almost a decade earlier in the Iranian subjects studied. Individuals aged over 40 and males seen to be more at risk as compared to others.

Cites

No record.

References

Cite

APA: Copy

ARDESHIRI, M., DAFTARIAN, N., MEHRABI, YAD ELAH, & AZIZI, F.. (2005). PREVALENCE OF OPHTHALMIC MANIFESTATIONS IN PATIENTS WITH DIFFUSE TOXIC GOITER IN TEHRAN. IRANIAN JOURNAL OF ENDOCRINOLOGY AND METABOLISM (IJEM), 7(3 (SN 27)), 217-222. SID. https://sid.ir/paper/27583/en

Vancouver: Copy

ARDESHIRI M., DAFTARIAN N., MEHRABI YAD ELAH, AZIZI F.. PREVALENCE OF OPHTHALMIC MANIFESTATIONS IN PATIENTS WITH DIFFUSE TOXIC GOITER IN TEHRAN. IRANIAN JOURNAL OF ENDOCRINOLOGY AND METABOLISM (IJEM)[Internet]. 2005;7(3 (SN 27)):217-222. Available from: https://sid.ir/paper/27583/en

IEEE: Copy

M. ARDESHIRI, N. DAFTARIAN, YAD ELAH MEHRABI, and F. AZIZI, “PREVALENCE OF OPHTHALMIC MANIFESTATIONS IN PATIENTS WITH DIFFUSE TOXIC GOITER IN TEHRAN,” IRANIAN JOURNAL OF ENDOCRINOLOGY AND METABOLISM (IJEM), vol. 7, no. 3 (SN 27), pp. 217–222, 2005, [Online]. Available: https://sid.ir/paper/27583/en

Related Journal Papers